The role of the soluble form of the EPO receptor must be tested not only for the potentially protective effects of EPO in clinical and AIPH, but also against the classical observations that Tibetans do not display marked erythrocytosis [285], and that their plasma EPO levels are essentially the same in high- and low-altitude Tibetans [286]. Here, EPO is linked to polycythemia.